TABLE OF CONTENTS
Volume 27, Issue 2 (7 January 2008)
Guest Editor
Top of pageIntroduction
Toll-like receptors in cancer
L A J O'Neill
Oncogene 27: 158-160; doi:10.1038/sj.onc.1210903
Reviews
Toll-like receptor 9 (TLR9) agonists in the treatment of cancer
A M Krieg
Oncogene 27: 161-167; doi:10.1038/sj.onc.1210911
TLR ligand suppression or enhancement of Treg cells? A double-edged sword in immunity to tumours
H Conroy, N A Marshall and K H G Mills
Oncogene 27: 168-180; doi:10.1038/sj.onc.1210910
Toll-like receptors and immune regulation: implications for cancer therapy
R-F Wang, Y Miyahara and H Y Wang
Oncogene 27: 181-189; doi:10.1038/sj.onc.1210906
TLR7 and TLR8 as targets in cancer therapy
M P Schön and M Schön
Oncogene 27: 190-199; doi:10.1038/sj.onc.1210913
Radiation therapy and Toll-like receptor signaling: implications for the treatment of cancer
R E Roses, M Xu, G K Koski and B J Czerniecki
Oncogene 27: 200-207; doi:10.1038/sj.onc.1210909
Obstacles to effective Toll-like receptor agonist therapy for hematologic malignancies
D E Spaner, R Foley, J Galipeau and J Bramson
Oncogene 27: 208-217; doi:10.1038/sj.onc.1210905
TLR signaling by tumor and immune cells: a double-edged sword
B Huang, J Zhao, J C Unkeless, Z H Feng and H Xiong
Oncogene 27: 218-224; doi:10.1038/sj.onc.1210904
Cancers take their Toll—the function and regulation of Toll-like receptors in cancer cells
R Chen, A B Alvero, D-A Silasi, K D Steffensen and G Mor
Oncogene 27: 225-233; doi:10.1038/sj.onc.1210907
Role of Toll-like receptors in gastrointestinal malignancies
M Fukata and M T Abreu
Oncogene 27: 234-243; doi:10.1038/sj.onc.1210908